New research published by The Washington Post suggests that popular GLP 1 medications like Ozempic, commonly used for diabetes and weight loss, may have a significant and devastating impact on bone health. While Zepbound vs Wegovy: Comparing Weight Loss, Dosage, Side Effects & Insurance Under a regulation proposed last week by the Centers for Medicare & Medicaid Services (CMS), Medicare and Medicaid recipients with obesity could gain access to coverage for costly GLP 1 receptor agonists like Ozempic & Possible Risk of Gastroparesis Shapiro Legal Group